Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Urinary Tract Infections 1Tuberculosis, Pulmonary 1Staphylococcal Infections 1Spasm 1Sleep Initiation and Maintenance Disorders 1Sepsis 1Seizures 1Schizophrenia, Treatment-Resistant 1Schizophrenia 1Retinitis 1Renal Insufficiency, Chronic 1Pulmonary Arterial Hypertension 1Pneumonia 1Pain 1Neutropenia 1Neoplasms 1Migraine Disorders 1Menorrhagia 1Meningitis, Bacterial 1Meningitis 1Lung Neoplasms 1Intraabdominal Infections 1Influenza, Human 1Inflammation 1Infections 1Hypoxia 1Hypokalemia 1Hypertension 1Hyperaldosteronism 1Herpes Simplex 1

Interventions

3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 5pimonidazole 4fluoroazomycin arabinoside 4Radiotherapy 4Injections 3Propofol 2Positron Emission Tomography Computed Tomography 2Drug Therapy 2Blood Specimen Collection 2pembrolizumab 1inositol trispyrophosphate 1gadobutrol 1fludarabine 1alovudine 1Thoracotomy 1Thoracic Surgery, Video-Assisted 1Temozolomide 1Surgical Procedures, Operative 1Sodium Chloride 1Saline Solution 1Pancreaticoduodenectomy 1Paclitaxel 1Oxygen 1Nitroglycerin 1NVP-BKM120 1Metformin 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Letrozole 1Hydroxychloroquine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hypoxia × Alfentanil × Clear all
NCT07395596 2026-02-24

Remimazolam for Bronchoscopy in High-Risk Patients

First Affiliated Hospital of Zhejiang University

Phase 4 Recruiting
360 enrolled

Hypoxia, Tuberculosis, Pulmonary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡